Buspar

DRUG2 trials

Sponsors

Par Pharmaceutical, Inc.

Conditions

To Determine Bioequivalence Under Fasting ConditionsTo Determine Bioequivalence Under Fed Conditions

Phase 1

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions

CompletedNCT00653419

Par Pharmaceutical, Inc.To Determine Bioequivalence Under Fasting Conditions

Start: 1998-06-30End: 1998-09-30Updated: 2008-04-04

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

CompletedNCT00652730

Par Pharmaceutical, Inc.To Determine Bioequivalence Under Fed Conditions

Start: 1998-07-31End: 1998-09-30Updated: 2017-09-26